Pretreatment with cisplatin enhances E7-specific CD8+ T-Cell-mediated antitumor immunity induced by DNA vaccination. - Wikidata - awgldk - TriplyDB

Pretreatment with cisplatin enhances E7-specific CD8+ T-Cell-mediated antitumor immunity induced by DNA vaccination.

Pretreatment with cisplatin enhances E7-specific CD8+ T-Cell-mediated antitumor immunity induced by DNA vaccination.

http://www.wikidata.org/entity/Q34732544

about

Combination of apigenin treatment with therapeutic HPV DNA vaccination generates enhanced therapeutic antitumor effects Exploitation of differential homeostatic proliferation of T-cell subsets following chemotherapy to enhance the efficacy of vaccine-mediated antitumor responses Cancer immunotherapy via combining oncolytic virotherapy with chemotherapy: recent advances Therapy of human papillomavirus-related disease Chemotherapeutics and radiation stimulate MHC class I expression through elevated interferon-beta signaling in breast cancer cells Reciprocal relationship of T regulatory cells and monocytic myeloid-derived suppressor cells in LP-BM5 murine retrovirus-induced immunodeficiency Myeloid derived suppressor cells - a new therapeutic target in the treatment of cancer.The innate and adaptive infiltrating immune systems as targets for breast cancer immunotherapy.DNA vaccines for cervical cancer Adoptive transfer of human papillomavirus E7-specific CTL enhances tumor chemoresponse through the perforin/granzyme-mediated pathway.Therapeutic HPV DNA vaccines.Treatment of tumors with vitamin E suppresses myeloid derived suppressor cells and enhances CD8+ T cell-mediated antitumor effects Treatment with demethylating agent, 5-aza-2'-deoxycytidine enhances therapeutic HPV DNA vaccine potency Delivery of chemotherapeutic agents using drug-loaded irradiated tumor cells to treat murine ovarian tumors.Chemoimmunotherapy.Sequential cisplatin therapy and vaccination with HPV16 E6E7L2 fusion protein in saponin adjuvant GPI-0100 for the treatment of a model HPV16+ cancer.Immunoprevention of human papillomavirus-associated malignancies The tipping point for combination therapy: cancer vaccines with radiation, chemotherapy, or targeted small molecule inhibitors Biology of human papillomavirus infection and immune therapy for HPV-related head and neck cancers.Post-chemotherapy T-cell recovery is a marker of improved survival in patients with advanced thoracic malignancies.Intralymphatic mRNA vaccine induces CD8 T-cell responses that inhibit the growth of mucosally located tumours Intratumoral injection of therapeutic HPV vaccinia vaccine following cisplatin enhances HPV-specific antitumor effects.Combination of treatment with death receptor 5-specific antibody with therapeutic HPV DNA vaccination generates enhanced therapeutic anti-tumor effects.Low-dose radiation enhances therapeutic HPV DNA vaccination in tumor-bearing hosts Enhancing therapeutic HPV DNA vaccine potency through depletion of CD4+CD25+ T regulatory cells.Targeting and retention of HPV16 E7 to the endoplasmic reticulum enhances immune tumour protection.Cervical Cancer: Development of Targeted Therapies Beyond Molecular Pathogenesis.RPN13/ADRM1 inhibitor reverses immunosuppression by myeloid-derived suppressor cells Immunologic treatments for precancerous lesions and uterine cervical cancer.Exploitation of the propulsive force of chemotherapy for improving the response to cancer immunotherapy.Calreticulin in the immune system: ins and outs Chemoimmunotherapy: reengineering tumor immunity.Novel mechanism of synergistic effects of conventional chemotherapy and immune therapy of cancer.Exploiting dendritic cells in the development of cancer vaccines.Chemotherapy and Oncolytic Virotherapy: Advanced Tactics in the War against Cancer.Cisplatin-induced antitumor immunomodulation: a review of preclinical and clinical evidence.Vaccines for established cancer: overcoming the challenges posed by immune evasion.Chemo-immunotherapy using saffron and its ingredients followed by E7-NT (gp96) DNA vaccine generates different anti-tumor effects against tumors expressing the E7 protein of human papillomavirus.Combination strategies to enhance the potency of monocyte-derived dendritic cell-based cancer vaccines.The importance of correctly timing cancer immunotherapy.

P2860

Q21284428-AAD14403-7711-4C1D-A963-1559843519F2 Q24604495-5269B655-11D6-433C-8FA6-CEB09B97E4EE Q26863779-99D2F286-5826-4CA4-9978-19199AA4935D Q27007473-65A4808E-333E-4AAD-8C7B-D17D5B513445 Q28481351-AFEC343A-7A18-46B2-AC8F-C26F5CCB8FB0 Q33573202-0B788AC5-3FF6-4E57-9363-C34BB9F138C5 Q33606107-B3F9ED07-D5E6-4AEA-80BC-75600CFB734A Q33660069-093966F1-AD98-4E8F-8ADD-C2FE8F783993 Q33680693-FE83A255-0482-485B-ADA1-4C8689C4F13C Q33713511-DC4A1567-2BE3-47C9-BB81-E5318594CFCB Q33936427-DDED823C-F519-4998-8C91-55F4BCBFCB58 Q33968479-5C1B1392-13FB-4B81-9FDE-760AEF2C413E Q34015916-299C7C30-E272-41AF-85C8-8181670E8ADE Q34053580-7A86F6C9-8A72-4305-BD91-A66B7A2A18EF Q34058792-88474FDA-6A38-4387-AD79-AFB4D299F58A Q34822738-4E899B64-2354-4570-BFF7-E0F20BF95965 Q35044376-46F103B6-B56D-450B-928C-7D5701FB3060 Q35975387-8BC8250E-764A-427E-BA67-616796A3C97E Q36099498-99131590-B5A1-4F3D-B6CB-F3095FA92623 Q36287976-A24AF490-681B-48DC-959B-3A7C28861E02 Q36638606-A63DA43D-B973-4E49-A1F2-DE9D7CAB4DD7 Q36949240-4A24C10E-137F-4D9A-B21D-CF7F2892C722 Q37038302-FE7CBE42-4385-43CF-A72E-0A008B1211B1 Q37109176-C5982A90-535A-4A9E-8314-DF33F7BF3AF6 Q37135741-66A9FA19-4034-48A0-8B80-AE38157A3B0E Q37295275-9586ACB3-AA18-4AC7-A986-D10000450D3A Q37579334-3EA4DFD5-6CD9-4D3E-A2CC-0BB61BE0B604 Q37684367-0326299F-BDC8-471B-AEEF-69171F9E9C82 Q37703113-1416B8D0-11D7-453E-BBF1-31F01EC3195D Q37969356-55E8DBCB-42A4-4FB5-93F9-D0CD1BADDD5D Q38041778-B7C51FC4-8A17-47B6-87D8-39683751DBB3 Q38079749-776221EF-8EE6-40E4-9CFB-9F673255EA47 Q38083001-6F3D54FB-F0D5-40EF-AE8E-E6892A89888C Q38148774-64C955A8-92C0-4BD0-8265-95E38F800F7F Q38223419-6F482421-89AA-47BA-AFAA-C42DBE7CB2D8 Q38247492-97A9F121-7930-40A0-9FA7-D50351F3652C Q38769021-F9315D37-7CC3-4C74-8761-83A5EE223368 Q38940518-81E0DF1A-FDE6-49D4-B1F4-B3351DD2D3ED Q38948897-64DE1E90-B5CD-4F9B-9AA8-E6662CB7A7CE Q38995979-7C7F1211-3BA1-4335-B6BF-C89484D06EDA

P2860

Pretreatment with cisplatin enhances E7-specific CD8+ T-Cell-mediated antitumor immunity induced by DNA vaccination.

http://www.wikidata.org/entity/Q34732544

description

2008 nî lūn-bûn

@nan

2008 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Pretreatment with cisplatin en ...... ty induced by DNA vaccination.

@ast

Pretreatment with cisplatin en ...... ty induced by DNA vaccination.

@en

Pretreatment with cisplatin en ...... ty induced by DNA vaccination.

@nl

type

label

Pretreatment with cisplatin en ...... ty induced by DNA vaccination.

@ast

Pretreatment with cisplatin en ...... ty induced by DNA vaccination.

@en

Pretreatment with cisplatin en ...... ty induced by DNA vaccination.

@nl

prefLabel

Pretreatment with cisplatin en ...... ty induced by DNA vaccination.

@ast

Pretreatment with cisplatin en ...... ty induced by DNA vaccination.

@en

Pretreatment with cisplatin en ...... ty induced by DNA vaccination.

@nl

P1433

Q34732544-D07785F1-8AA1-4348-9B7B-01444E171EFB

P1476

Q34732544-B325C902-954C-445E-A17B-ACF880F7265B

P2093

Q34732544-063B83EF-D7AA-4260-981B-1337B5706C9C

Q34732544-1D4F0464-91B3-4C3E-8051-FCB61DD88C3B

Q34732544-3382EFBE-C046-44C8-A241-D91A184C2FE0

Q34732544-6D92477E-C837-413D-A9A5-A17770BD8B1F

Q34732544-910EC39B-2BBC-4B23-AFCB-B7635EAA78D3

Q34732544-BC3756BA-3EE6-4531-AE88-C05535D6B6A4

Q34732544-C1BD3F42-7383-47C4-A450-B82477B7B19F

Q34732544-D36D11BD-5DFB-4FFD-B19A-49245824394A

Q34732544-DEC85F5B-B4A5-4A76-BDF3-92968F927258

Q34732544-E1576CBB-6EEC-4A05-BFFF-1EE027AC96A0

P2860

Q34732544-20478D4E-5C99-4148-8081-1B3D10DD8FA6

Q34732544-3137C6E2-5128-414F-82D3-2BB098E11A82

Q34732544-54528CDA-1E90-4B1D-8BE0-EBEC1323EC4E

Q34732544-62B9B752-1854-4BF0-9477-57FEC1737C0D

Q34732544-7BDC3172-2564-49EB-90CA-5D17A9263F20

Q34732544-90A8F7B2-EFFC-411B-B339-FDD0F4127F93

Q34732544-B481C85B-E8A2-4EF9-8A30-5AE7BABD4A2D

Q34732544-B4B22A0C-F76F-4742-B4AF-5D317A39E09D

Q34732544-BD9764A9-2857-4CC2-9168-CC78ECDC87BA

Q34732544-D193800D-9B90-43DC-AA98-FCDC1FBA3B2B

P304

Q34732544-FFC73C3C-ACBC-47D6-ADB4-80DE0C38831B

P31

Q34732544-7692F32D-C410-41B5-9EAD-BC98B176F17C

P356

Q34732544-FCC11CF6-CCE1-48A1-8E4B-BE3FB4C2945C

P407

Q34732544-D2D8EB28-93D2-4EFE-B0F8-AB0350F67363

P433

Q34732544-F3AE094F-CAF5-448D-AD99-9CCB441F02C9

P478

Q34732544-48A3AD59-E722-42F8-8F22-B16EDC980933

P577

Q34732544-83A17758-ADFE-4AA2-BAC1-95CDA6445CC5

P5875

Q34732544-CA94F536-56FA-405D-9E59-AD3D9C03ED71

P698

Q34732544-72E123FF-4D61-49D3-B002-B629D44F7BA8

P932

Q34732544-304C39A9-5815-480F-832A-02531054295B

P356

1078-0432.CCR-08-0037

P1433

Clinical Cancer Research

P1476

Pretreatment with cisplatin en ...... ty induced by DNA vaccination.

@en

P2093

Archana Monie

http://www.w3.org/2001/XMLSchema#string

Cheng-Tao Lin

http://www.w3.org/2001/XMLSchema#string

Chi-Mu Chuang

http://www.w3.org/2001/XMLSchema#string

Chien-Fu Hung

http://www.w3.org/2001/XMLSchema#string

Chih-Wen Tseng

http://www.w3.org/2001/XMLSchema#string

Cornelia Trimble

http://www.w3.org/2001/XMLSchema#string

Daejin Kim

http://www.w3.org/2001/XMLSchema#string

Liangmei He

http://www.w3.org/2001/XMLSchema#string

Ronald D Alvarez

http://www.w3.org/2001/XMLSchema#string

T-C Wu

http://www.w3.org/2001/XMLSchema#string

P2860

Calreticulin, a Ca2+-binding chaperone of the endoplasmic reticulum

DNA vaccines: immunology, application, and optimization*

Chemotherapy and tumor immunity: an unexpected collaboration

Improving DNA vaccine potency via modification of professional antigen presenting cells.

Epigallocatechin-3-gallate enhances CD8+ T cell-mediated antitumor immunity induced by DNA vaccination.

Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen.

Intradermal administration of DNA vaccines combining a strategy to bypass antigen processing with a strategy to prolong dendritic cell survival enhances DNA vaccine potency.

Leveraging the activity of tumor vaccines with cytotoxic chemotherapy.

Biochemical mechanisms of cisplatin cytotoxicity.

Enhancing DNA vaccine potency by modifying the properties of antigen-presenting cells.

P304

3185-3192

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-08-0037

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2008-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5261027

http://www.w3.org/2001/XMLSchema#string

P698

18483387

http://www.w3.org/2001/XMLSchema#string

P932

3066100

http://www.w3.org/2001/XMLSchema#string